JOANN BALL: Open Payments
NPI 1922634351 · PALM DESERT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,301 in 163 payments from 16 companies in 2025. Trend: 2023 $1,164 · 2024 $1,020 · 2025 $5,301
Food & beverage: $5,301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $1,114 |
| Amgen Inc. | 30 | $868 |
| UCB, Inc. | 19 | $791 |
| AstraZeneca Pharmaceuticals LP | 10 | $412 |
| Mallinckrodt Hospital Products Inc. | 10 | $399 |
| Janssen Biotech, Inc. | 12 | $369 |
| Novartis Pharmaceuticals Corporation | 11 | $319 |
| Lilly USA, LLC | 7 | $267 |
| Aurinia Pharma U.S., Inc. | 7 | $218 |
| GlaxoSmithKline, LLC. | 6 | $197 |
Products named: Bimzelx, RINVOQ, OTEZLA, SAPHNELO, ACTHAR, SKYRIZI, TREMFYA, EVENITY.
Industry payments across CA — which companies pay providers there.
